Acadian Asset Management LLC Trinity Biotech PLC Transaction History

Acadian Asset Management LLC

$32.2 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$0.38 - $0.7 $14,688 - $27,057	-38,654 Reduced 5.34%	684,882 $292,000
Q3 2023 Nov 13, 2023	SELL	$0.68 - $1.08 $3,004 - $4,771	-4,418 Reduced 0.61%	723,536 $526,000
Q2 2023 Aug 07, 2023	SELL	$0.84 - $1.14 $12,264 - $16,644	-14,600 Reduced 1.97%	727,954 $701,000
Q1 2023 May 11, 2023	SELL	$0.87 - $1.18 $7,529 - $10,212	-8,655 Reduced 1.15%	742,554 $696,000
Q4 2022 Feb 14, 2023	SELL	$0.98 - $6.15 $8,819 - $55,343	-8,999 Reduced 1.18%	751,209 $741,000
Q2 2022 Aug 09, 2022	SELL	$0.96 - $1.44 $53,042 - $79,564	-55,253 Reduced 6.78%	760,208 $931,000
Q1 2022 May 12, 2022	SELL	$0.92 - $1.44 $25,817 - $40,409	-28,062 Reduced 3.33%	815,461 $862,000
Q4 2021 Feb 10, 2022	SELL	$1.43 - $2.25 $16,944 - $26,660	-11,849 Reduced 1.39%	843,523 $1.2 Million
Q3 2021 Nov 12, 2021	BUY	$1.82 - $2.94 $31,253 - $50,485	17,172 Added 2.05%	855,372 $1.84 Million
Q2 2021 Aug 11, 2021	BUY	$2.77 - $4.18 $235,192 - $354,911	84,907 Added 11.27%	838,200 $2.46 Million
Q1 2021 May 11, 2021	BUY	$3.26 - $6.64 $420,064 - $855,590	128,854 Added 20.64%	753,293 $2.83 Million
Q4 2020 Feb 11, 2021	BUY	$1.95 - $4.77 $213,181 - $521,475	109,324 Added 21.22%	624,439 $2.38 Million
Q3 2020 Nov 09, 2020	BUY	$1.68 - $3.17 $578,074 - $1.09 Million	344,092 Added 201.2%	515,115 $1.04 Million
Q2 2020 Aug 12, 2020	BUY	$0.88 - $2.55 $150,500 - $436,108	171,023 New	171,023 $373,000
Q4 2018 Feb 07, 2019	SELL	$2.14 - $4.26 $12,444 - $24,771	-5,815 Closed	0 $0
Q2 2018 Jul 24, 2018	BUY	$4.46 - $5.2 $25,934 - $30,238	5,815 New	5,815 $29,000

Others Institutions Holding TRIB

# of Institutions

Shares Held

30.2K

Call Options Held

Put Options Held

Wealthsource Partners, LLC

30.2K
Shares

$36,844
0.0% of portfolio

View Full List

About TRINITY BIOTECH PLC

Ticker TRIB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 38,107,600
Market Cap $46.5M
Description
Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious dis...

More about TRIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Account